Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy.

Higher costs during the first 45 days after evidence of the presence of TRD and during persistence on a late line relative to persistence on the early-line therapy suggest there are benefits to using more effective treatments earlier.